Levosimendan in cardiogenic shock and low cardiac output syndrome

Vladimir Lomivorotov; Martina Baiardo Redaelli; Vladimir Boboshko

doi:10.1007/978-3-030-71917-3_12

Levosimendan in cardiogenic shock and low cardiac output syndrome

Vladimir Lomivorotov
, Martina Baiardo Redaelli
, Vladimir Boboshko

Department of Anesthesiology and Perioperative Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Low cardiac output syndrome (LCOS) is the most common and the most serious complication after cardiac surgery and is associated with increased rates of morbidity and mortality [1]. This syndrome is characterized by impaired heart function, causing a reduced oxygen delivery with further hypoxia [2]. The universally definition of LCOS includes decreases in the cardiac index (CI) to less than 2.0 L/min/m² and a systolic blood pressure below 90 mmHg, associated with tissue hypoperfusion (clammy skin, cold periphery, oliguria, elevated lactate level, confusion) in the absence of hypovolemia.

Original language	English (US)
Title of host publication	Reducing Mortality in Critically Ill Patients
Publisher	Springer International Publishing
Pages	107-114
Number of pages	8
ISBN (Electronic)	9783030719173
ISBN (Print)	9783030719166
DOIs	https://doi.org/10.1007/978-3-030-71917-3_12
State	Published - Jun 8 2021

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1007/978-3-030-71917-3_12

Cite this

@inbook{3040e79894ec4ca182b11946596ef47a,

title = "Levosimendan in cardiogenic shock and low cardiac output syndrome",

abstract = "Low cardiac output syndrome (LCOS) is the most common and the most serious complication after cardiac surgery and is associated with increased rates of morbidity and mortality [1]. This syndrome is characterized by impaired heart function, causing a reduced oxygen delivery with further hypoxia [2]. The universally definition of LCOS includes decreases in the cardiac index (CI) to less than 2.0 L/min/m2 and a systolic blood pressure below 90 mmHg, associated with tissue hypoperfusion (clammy skin, cold periphery, oliguria, elevated lactate level, confusion) in the absence of hypovolemia.",

author = "Vladimir Lomivorotov and Redaelli, \{Martina Baiardo\} and Vladimir Boboshko",

year = "2021",

month = jun,

day = "8",

doi = "10.1007/978-3-030-71917-3\_12",

language = "English (US)",

isbn = "9783030719166",

pages = "107--114",

booktitle = "Reducing Mortality in Critically Ill Patients",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Levosimendan in cardiogenic shock and low cardiac output syndrome

AU - Lomivorotov, Vladimir

AU - Redaelli, Martina Baiardo

AU - Boboshko, Vladimir

PY - 2021/6/8

Y1 - 2021/6/8

N2 - Low cardiac output syndrome (LCOS) is the most common and the most serious complication after cardiac surgery and is associated with increased rates of morbidity and mortality [1]. This syndrome is characterized by impaired heart function, causing a reduced oxygen delivery with further hypoxia [2]. The universally definition of LCOS includes decreases in the cardiac index (CI) to less than 2.0 L/min/m2 and a systolic blood pressure below 90 mmHg, associated with tissue hypoperfusion (clammy skin, cold periphery, oliguria, elevated lactate level, confusion) in the absence of hypovolemia.

AB - Low cardiac output syndrome (LCOS) is the most common and the most serious complication after cardiac surgery and is associated with increased rates of morbidity and mortality [1]. This syndrome is characterized by impaired heart function, causing a reduced oxygen delivery with further hypoxia [2]. The universally definition of LCOS includes decreases in the cardiac index (CI) to less than 2.0 L/min/m2 and a systolic blood pressure below 90 mmHg, associated with tissue hypoperfusion (clammy skin, cold periphery, oliguria, elevated lactate level, confusion) in the absence of hypovolemia.

UR - https://www.scopus.com/pages/publications/85150669952

UR - https://www.scopus.com/pages/publications/85150669952#tab=citedBy

U2 - 10.1007/978-3-030-71917-3_12

DO - 10.1007/978-3-030-71917-3_12

M3 - Chapter

AN - SCOPUS:85150669952

SN - 9783030719166

SP - 107

EP - 114

BT - Reducing Mortality in Critically Ill Patients

PB - Springer International Publishing

ER -

Levosimendan in cardiogenic shock and low cardiac output syndrome

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this